Milestone Scientific Inc. (NYSEAMERICAN:MLSS) was up 12.5% during mid-day trading on Monday . The stock traded as high as $0.64 and last traded at $0.63, approximately 204,222 shares were traded during mid-day trading. A decline of 23% from the average daily volume of 266,474 shares. The stock had previously closed at $0.56.
Separately, Maxim Group restated a “buy” rating and issued a $1.00 price target on shares of Milestone Scientific in a research report on Friday.
Milestone Scientific (NYSEAMERICAN:MLSS) last issued its earnings results on Wednesday, August 14th. The medical instruments supplier reported ($0.02) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.02). The company had revenue of $2.26 million for the quarter.
Institutional investors have recently added to or reduced their stakes in the business. Private Capital Group LLC raised its holdings in shares of Milestone Scientific by 678.5% in the second quarter. Private Capital Group LLC now owns 31,139 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 27,139 shares during the last quarter. Commonwealth Equity Services LLC raised its holdings in shares of Milestone Scientific by 36.3% in the second quarter. Commonwealth Equity Services LLC now owns 95,122 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 25,310 shares during the last quarter. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Milestone Scientific in the first quarter valued at about $39,000. Finally, Vanguard Group Inc. raised its holdings in shares of Milestone Scientific by 36.4% in the second quarter. Vanguard Group Inc. now owns 134,487 shares of the medical instruments supplier’s stock valued at $48,000 after purchasing an additional 35,886 shares during the last quarter.
Milestone Scientific Company Profile (NYSEAMERICAN:MLSS)
Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances.
Featured Article: What is the Difference Between Common Shares and Convertible Shares?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.